Vanguard Fiduciary Trust’s CalciMedica CALC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.2K	Hold	45,829	–	–	﹤0.01%	3876
2026 Q1	$24.7K	Buy	+45,829	New	+$93K	﹤0.01%	3926

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust's CALC Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its CalciMedica (CALC) position steady in Q2 2026 at 45,829 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3876.

Vanguard Fiduciary Trust first reported a position in CALC in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Vanguard Fiduciary Trust held 45,829 shares of CalciMedica worth $47.2K as of Q2 2026.
Vanguard Fiduciary Trust left its CalciMedica share count unchanged in Q2 2026.
CalciMedica made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3876 holding.
Vanguard Fiduciary Trust first reported a position in CalciMedica in Q1 2026 and has held it in 2 quarters since.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.